Vertex gets NDA going for CF triple combo; Disarm woos rare disease expert Alvin Shih as CEO

Retrieved on: 2019-07-21 22:48:45

Tags for this article:

Click the tags to see associated articles and topics

Vertex gets NDA going for CF triple combo; Disarm woos rare disease expert Alvin Shih as CEO. View article details on hiswai:

Excerpt

<div>Incubated out of <b>Atlas Venture's</b> Cambridge, MA hatching grounds, the biotech is zeroing in on SARM1 in hopes of disrupting the process of axonal ...</div>

Article found on:

View Original Article